International journal of nanomedicine · 2025
CD42-Enriched Extracellular Vesicles Contribute to Increased Platelet Aggregation and Possibly Organ Damage in Patients with Burn Injury Complicated by Sepsis.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Schiavello Martina, Vizio Barbara, Bosco Ornella, Mariano Filippo, Bruno Stefania, Pensa Anna, Cagna Vallino Paolo, Dini Chiara, Montrucchio Giuseppe, Lupia Enrico
Аннотация
BACKGROUND: Sepsis is the leading cause of death in patients with burn injury, in whom it represents a real diagnostic challenge. Here, we studied extracellular vesicles (EVs) released during sepsis in burn patients by multiplexed phenotyping and explored their role in promoting platelet aggregation.
METHODS: We enrolled 33 burn patients, 23 with (Burn Septic Patients - BSP) and 10 without sepsis (Burn Non-Septic Patients - BnSP), and 10 healthy subjects (HS). EVs, isolated by ultracentrifugation or precipitation-based methods, were characterized by Nanoparticle Tracking Analysis, Transmission Electron Microscopy, and flow cytometry, and their surface antigens studied by bead-based multiplex flow cytometry. Platelet aggregation was studied in platelet-rich plasma using light-transmission aggregometry.
RESULTS: EVs from BSP expressed a specific pattern of epitopes distinct from those from BnSP and HS. Specifically, EVs from BSP showed an increase in CD42a expression compared to BnSP-(p<0.05) and HS-(p<0.0001) derived EVs. Moreover, CD42a-EVs expression increased according to sepsis severity in BSP. In vitro, EVs from BSP, but not from HS, primed platelet aggregation, an effect reduced by an anti-CD42 neutralizing monoclonal antibody.
CONCLUSION: Our results suggest the potential of CD42a-enriched EVs as diagnostic and prognostic markers of sepsis in burn patients and their role in increasing platelet activation in these patients.
METHODS: We enrolled 33 burn patients, 23 with (Burn Septic Patients - BSP) and 10 without sepsis (Burn Non-Septic Patients - BnSP), and 10 healthy subjects (HS). EVs, isolated by ultracentrifugation or precipitation-based methods, were characterized by Nanoparticle Tracking Analysis, Transmission Electron Microscopy, and flow cytometry, and their surface antigens studied by bead-based multiplex flow cytometry. Platelet aggregation was studied in platelet-rich plasma using light-transmission aggregometry.
RESULTS: EVs from BSP expressed a specific pattern of epitopes distinct from those from BnSP and HS. Specifically, EVs from BSP showed an increase in CD42a expression compared to BnSP-(p<0.05) and HS-(p<0.0001) derived EVs. Moreover, CD42a-EVs expression increased according to sepsis severity in BSP. In vitro, EVs from BSP, but not from HS, primed platelet aggregation, an effect reduced by an anti-CD42 neutralizing monoclonal antibody.
CONCLUSION: Our results suggest the potential of CD42a-enriched EVs as diagnostic and prognostic markers of sepsis in burn patients and their role in increasing platelet activation in these patients.